1,3,5-TRI(4-TERT-BUTYL-2,6-DIMETHYL-3-HYDROXYBENZYL)-1,3,5-TRIAZINE-2,4,6(1H,3H,5H)-TRIONE
UNII 253H13NWCQ
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,3,5-tri(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-1,3,5-triazine-2,4,6(1h,3h,5h)-trione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 253H13NWCQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 40601-76-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C42H57N3O6 XYXJKPCGSGVSBO-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,3,5-tri(4-tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-1,3,5-triazine-2,4,6(1h,3h,5h)-trione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.